Klaus Tschaikowsky
Impact in
-
- Nosocomial Infections in ICU
- Intensive Care Unit Cognitive Disorders
- Thermal Regulation in Medicine
- Epidemiology top 2%
- Sepsis Diagnosis and Treatment
Papers in
- Immunology 11
- Immune Response and Inflammation 9
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 3
- Epidemiology 17
- Sepsis Diagnosis and Treatment 17
- Co-authors
- Michael MeisnerAndreas HutzlerChristoph SchickJ. SchmidtJ. SchüttlerJoachim SchmidtThomas PalmaersM. Schywalsky
- Journals
- Intensive Care Medicine (8 papers)Critical Care Medicine (8 papers)Anesthesiology (3 papers)Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2 papers)Journal of Visualized Experiments (2 papers)
- Partner nations
- GermanyUnited StatesNetherlands
In The Last Decade
Klaus Tschaikowsky
38 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 111
- Critical Care and Intensive Care Medicine 514
- Epidemiology 1.3k
- Family Practice 60
- Immunology 438
- Nephrology 115
Countries citing papers authored by Klaus Tschaikowsky
This map shows the geographic impact of Klaus Tschaikowsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klaus Tschaikowsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klaus Tschaikowsky more than expected).
Fields of papers citing papers by Klaus Tschaikowsky
This network shows the impact of papers produced by Klaus Tschaikowsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klaus Tschaikowsky. The network helps show where Klaus Tschaikowsky may publish in the future.
Co-authors
The 25 scholars most cited alongside Klaus Tschaikowsky, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 4 | |
| 2 | 2010 | 112 | |
| 3 | 2004 | 57 | |
| 4 | 2004 | 16 | |
| 5 | 2002 | 19 | |
| 6 | 2002 | 41 | |
| 7 | Phase 1 study with recombinant chimeric monoclonal antibody against human CD14 (IC14) in patients with severe sepsis | 2001 | 3 |
| 8 | 2001 | 180 | |
| 9 | 2001 | 12 | |
| 10 | 2000 | 73 | |
| 11 | 2000 | 87 | |
| 12 | 2000 | 16 | |
| 13 | 2000 | 21 | |
| 14 | 1998 | 278 | |
| 15 | 1998 | 10 | |
| 16 | 1997 | 29 | |
| 17 | 1994 | 22 | |
| 18 | 1994 | 23 | |
| 19 | 1994 | 18 | |
| 20 | 1993 | 30 |
About Klaus Tschaikowsky
Klaus Tschaikowsky is a scholar working on Immunology, Epidemiology, Critical Care and Intensive Care Medicine, Anesthesiology and Pain Medicine and Cardiology and Cardiovascular Medicine, having authored 38 papers that have together received 2.2k indexed citations. Recurring topics across this work include Sepsis Diagnosis and Treatment (17 papers), Hemodynamic Monitoring and Therapy (9 papers), Immune Response and Inflammation (9 papers), Cardiac, Anesthesia and Surgical Outcomes (5 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers), Sphingolipid Metabolism and Signaling (3 papers), Nitric Oxide and Endothelin Effects (3 papers) and S100 Proteins and Annexins (2 papers). The work is most often cited by research in Critical Care and Intensive Care Medicine (514 citations), Epidemiology (1.3k citations), Family Practice (60 citations), Immunology (438 citations) and Nephrology (115 citations). Klaus Tschaikowsky has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include Michael Meisner, Andreas Hutzler, Christoph Schick, J. Schmidt, J. Schüttler, Joachim Schmidt, Thomas Palmaers, M. Schywalsky, Frank Bremer and Martin Radespiel‐Tröger. Their work appears in journals such as Intensive Care Medicine, Critical Care Medicine, Anesthesiology, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research and Journal of Visualized Experiments.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.